Protective effects of propolis extract against nicotine-evoked pulmonary and hepatic damage

Author(s):  
Shimaa Khaled ◽  
Mirhan N. Makled ◽  
Manar A. Nader
Molecules ◽  
2017 ◽  
Vol 22 (10) ◽  
pp. 1654 ◽  
Author(s):  
Bolajoko Ogunyinka ◽  
Babatunji Oyinloye ◽  
Foluso Osunsanmi ◽  
Andrew Opoku ◽  
Abidemi Kappo

Toxicology ◽  
2008 ◽  
Vol 244 (1) ◽  
pp. 25-34 ◽  
Author(s):  
Marcus V. Terneus ◽  
J. Michael Brown ◽  
A. Betts Carpenter ◽  
Monica A. Valentovic

2021 ◽  
Author(s):  
Ayman Ahmed Bassiouny El-Amawy ◽  
Samir Attia Mohammed Zaahkouk ◽  
Hesham Gamal Abdel Rasheed ◽  
Bassem Elsayed Elaraby Mohammed

Abstract The study was designed to clarify the hepato-renal protective effects of propolis extract against heavy metals-induced toxicity via oral administration to the males of albino rats. Lead (Pb), Nickel (Ni), Cadmium (Cd), and Antimony (Sb) are toxic heavy metals have the ability to produce reactive radicals in the biological systems causing public and animals health hazards through disrupting balances between pro-oxidant and antioxidant defense system, resulting in excessive reactive oxygen species (ROS) production. The most commonly affected organs are liver and kidney. Propolis is a natural product with different shapes and resinous substance collected by honey bees, it attenuates many diseases damage due to its anti-oxidative action and its potentiality to minimize the deleterious effects of free radicals on tissues. The concentrations of Pb, Cd, Ni and Sb as well as the activities of antioxidants endogenous enzymes including; glutathione peroxidase (Gpx), glutathione reductase (GR), catalase (CAT), and superoxide dismutase (SOD) were all determined in the tissues of liver and kidney; while aspartate transaminase (ASAT), alanine transaminase (ALAT), total protein (TP), urea and createnine, were measured in the serum of experimental rats beside histopathologicl examination in the tissues of liver and kidney. The oral administration of propolis provided a significantly therapeutic role against multi-metals-induced hepato-renal toxicity with relative improving to histopathological changes because of its scavenging and chelating properties as concluded from the present investigation.


2015 ◽  
Vol 6 (2) ◽  
pp. 513-524 ◽  
Author(s):  
Yan Nie ◽  
Daoyuan Ren ◽  
Xinshan Lu ◽  
Yanfei Sun ◽  
Xingbin Yang

The present study reports the phenolic profiles and antioxidant and hepatoprotective properties of Red Fuji apple peel polyphenolic extract (APP) and its flesh polyphenolic extract (AFP) against CCl4-induced acute hepatic damage in mice.


1990 ◽  
Vol 22 (5) ◽  
pp. 256-262 ◽  
Author(s):  
M. Shinohara ◽  
K. Kayashima ◽  
K. Konomi

2021 ◽  
Vol 27 (2) ◽  
pp. 201-209
Author(s):  
Sijia Li ◽  
Kai Hu ◽  
Longjiang Li ◽  
Yi Shen ◽  
Jiayi Huang ◽  
...  

Increasing evidence indicates that signal transducer and activator of transcription 3 (STAT3), a vital transcription factor, plays crucial roles in the regulation of inflammation. STAT3 has become a novel therapeutic target for intervention in inflammation-related disorders. However, it remains unclear whether STAT3 plays a part in acute hepatic damage. To investigate the effects of STAT3 here, LPS/d-GalN-induced hepatic damage was induced in mice, the STAT3 inhibitor Stattic was administered, and the degree of liver injury, inflammation, and hepatocyte apoptosis were investigated. The results showed that Stattic mitigated the hepatic morphologic abnormalities and decreased the level of aminotransferase in LPS/D-GalN-insulted mice. The results also indicated that Stattic decreased the levels of TNF-α and IL-6, prevented the activation of the caspase cascade, suppressed cleavage of PARP, and decreased the quantity of TUNEL-positive cells. These results suggest that Stattic provided protective benefits in LPS/d-GalN-induced hepatic damage, and the protective effects might be associated with its anti-inflammatory and anti-apoptotic effects. Therefore, STAT3 might become a novel target for intervening in inflammation-based and apoptosis-based hepatic disorders.


1988 ◽  
Vol 8 (4) ◽  
pp. 380-383
Author(s):  
Akemi ICHIKI ◽  
Kunio ISHIZUKA ◽  
Nobuyuki MATSUMOTO ◽  
Yoshihisa MARUNO ◽  
Isao MATSUMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document